Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$181.47 USD
-0.56 (-0.31%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $181.25 -0.22 (-0.12%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $0.85 | 0.00% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.50 per share. This reflects a positive earnings surprise of 72.00%. Look out for KRYS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.85 per share, reflecting a year-over-year increase of 226.87%.
Earnings History
Price & Consensus
Zacks News for KRYS
AstraZeneca's Enhertu sBLA Gets FDA Priority Tag for Expanded Use
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services